Atlas Trials

SpyGlass Pharma, Inc.

6 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch SpyGlass Pharma, Inc.

RecordFirmDate
Evaluation of the Safety, Efficacy, Dose Response of the Bimatoprost Drug Ring System (BIM-DRS) in Pseudophakic Patients Diagnosed With Open Angle Glaucoma or Ocular Hypertension (NCT07641296)SpyGlass Pharma, Inc.2026-07-31
Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone) (NCT07218796)SpyGlass Pharma, Inc.2025-10-28
Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine) (NCT07218783)SpyGlass Pharma, Inc.2025-10-15
Evaluation of the Bimatoprost Implant System Used in Combination With the SpyGlass Intraocular Lens Compared to Timolol Ophthalmic Solution (NCT06120842)SpyGlass Pharma, Inc.2023-10-13
Observational Study to Evaluate Long Term Outcomes for Ocular Hypertension and Glaucoma Patients Treated With the SpyGlass Bimatoprost Implant System / IOL Combination (NCT07154810)SpyGlass Pharma, Inc.2023-03-16
Evaluation of the Safety and Effectiveness of the Bimatoprost Implant System / IOL Combination in Patients With Ocular Hypertension or Mild to Moderate Open-angle Glaucoma (NCT07154797)SpyGlass Pharma, Inc.2022-04-21

Track SpyGlass Pharma, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.